Ipsen

White arrow on a road pointing to the rising sun
Biotech

Ipsen unveils data that drove anti-wrinkle jab into phase 3

Ipsen reported an increase in the proportion of people with significant improvements in frown lines 24 weeks after treatment.
Nick Paul Taylor May 18, 2026 5:06am
Sunken ships from above

Ipsen scuttles liver disease candidates from Albireo acquisition

May 6, 2026 3:10pm
Parachute over a desert

BioNTech founders to pioneer new company—Chutes & Ladders

Mar 13, 2026 8:30am
saker falcon

Ipsen fails to land pivotal rare disease trial

Dec 19, 2025 3:37pm
Illustration connected puzzle pieces with the acronym MA

Ipsen inks €1B buyout of French biotech ImCheck

Oct 22, 2025 10:33am
Graphic image of a pen signing a signature while two strangelooking business people cheer

Ipsen taps Biomunex's MAITs to treat solid tumors in $610M bet

Dec 3, 2024 6:00am